Condition (MeSH)
Intussusception
ClinicalTrials.gov lists 30 trials for Intussusception or a narrower condition beneath it. GlaxoSmithKline has the most among industry and government lead sponsors, with 6.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
30 of the 30 trials are tagged with Intussusception itself; the rest are tagged with a narrower condition beneath it.
When did Intussusception trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 3 |
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 3 |
| 2019 | 2 |
| 2017 | 1 |
| 2016 | 3 |
| 2015 | 2 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 30 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Intussusception trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 3 |
| Not applicable | 11 |
| Observational | 14 |
How many Intussusception trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 4 |
| Recruiting | 1 |
| Completed | 21 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Intussusception trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| Ethicon Endo-Surgery | 1 |
| Ethicon Endo-Surgery (Europe) GmbH | 1 |
| Ibn Al Nafees Hospital | 1 |
Which drugs are being tested for Intussusception? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| METHYLPREDNISOLONE | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Rotarix TM | 3 |
| data collection | 2 |
| Rotarix®, with other routine vaccines | 1 |
| RotaTeq®, with other routine vaccines | 1 |
| Indocyanine Green dye | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Intussusception trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Gastroenteritis | 3 | 2 |
| Asthma | 2 | 1 |
| Pneumonia | 2 | 1 |
| Postprocedural haemorrhage | 2 | 1 |
| Urinary retention | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Intussusception? (96)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Successful Treatment of Early Presenting Intussusception With a Single Dose of Corticosteroid: A Prospective Randomized Controlled Trial. | Journal of pediatric surgery | 2025 | Yes |
| Transanal minimally invasive (TAMIS) mucosal resection with muscular plication for patients with obstructed defecation syndrome-A prospective pilot study. | Techniques in coloproctology | 2025 | Yes |
| Effects of sedatives on radiologic enema reduction in children with ileocolic intussusception: A systematic review and meta-analysis. | European journal of radiology | 2024 | Yes |
| Liberal surgical laparoscopy reduction for acute intussusception: experience from a tertiary pediatric institute. | Scientific reports | 2024 | Yes |
| Intussusception Management in Children: A 15-Year Experience in a Referral Center. | Indian journal of pediatrics | 2023 | Yes |
Showing 5 of 96 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.